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Homeostasisandwoundhealing relyonstemcells (SCs)
whose activity and directed migration are often gov-
erned byWnt signaling. In dissecting how this pathway
integrates with the necessary downstream cytoskeletal
dynamics,wediscovered thatGSK3b, akinase inhibited
by Wnt signaling, directly phosphorylates ACF7, a >
500 kDa microtubule-actin crosslinking protein abun-
dant in hair follicle stem cells (HF-SCs). We map
ACF7’sGSK3b sites to themicrotubule-binding domain
and show that phosphorylation uncouples ACF7 from
microtubules. Phosphorylation-refractile ACF7 rescues
overall microtubule architecture, but phosphorylation-
constitutive mutants do not. Neither mutant rescues
polarizedmovement, revealing that phospho-regulation
must be dynamic. This circuitry is physiologically rele-
vant and depends upon polarized GSK3b inhibition at
the migrating front of SCs/progeny streaming from
HFs during wound repair. Moreover, only ACF7 and
not GSKb-refractile-ACF7 restore polarized microtu-
bule-growth and SC-migration to ACF7 null skin. Our
findings provide insights into how this conserved spec-
traplakin integrates signaling, cytoskeletal dynamics,
and polarized locomotion of somatic SCs.INTRODUCTION
Directional cellmovement is essential for developmentalmorpho-
genesis, tumor metastasis, and wound repair. A typical migrating
cell adopts front-rear polarity with asymmetrical distribution of
signaling molecules and cytoskeletal components. During estab-
lishment of polarity, temporal capture andstabilization ofmicrotu-
bules (MTs) occur near filamentous actin (F-actin)-enriched
leading edges, which enable reorientation of the MT-organizing
center and Golgi complex to ensure biased vesicular transport
for directional migration (Etienne-Manneville, 2004; Siegrist andDoe, 2007). Among many regulatory molecules required for cell
migration, the ubiquitously-expressed serine and threonine
kinaseglycogen synthasekinase3b (GSK3b) is particularly impor-
tant in transmitting upstream signaling necessary for establishing
cell polarity and guiding directional movement (Sun et al., 2009).
In contrast tomost other protein kinases,GSK3bactivity is high
in nonstimulated cells, but it is dampened at the leading edge of
scratch-wounded astrocytes and endodermal cells in vitro and in
developing neurons of brain slices ex vivo (Etienne-Manneville
and Hall, 2003; Kodama et al., 2003; Yoshimura et al., 2006).
In vitro, GSK3b inhibition and cell polarity are known to be
provoked by CDC42 (Etienne-Manneville and Hall, 2003).
In vivo, GSK3b activity is inhibited by Wnt signaling, which in
turn leads to b-catenin stabilization, which plays a critical and
near universal role in stem cell (SC) activation and migration
(Fuchs, 2009;Nusse et al., 2008). Despite this tantalizing connec-
tion, the possible physiological relevance among Wnt signaling,
SC activation, and cytoskeletal remodeling remains unclear.
Another key unaddressed question is how GSK3b regulates the
dynamic changes in MT organization and stabilization that tran-
spire during polarized movements of somatic SCs.
Hair follicles (HFs) provide an ideal paradigm to address these
issues. Adult HFs undergo homeostasis through cyclical bouts of
active growth (anagen), regression (catagen), and rest (telogen)
(Figure S1A available online). They also participate in epidermal
re-epithelialization during wound healing (Blanpain and Fuchs,
2009; Ito et al., 2005; Tumbar et al., 2004). Both processes rely
upon a resident population of SCs, which reside in a specific
niche called the bulge, located at the base of the noncycling
portion of the HF (Figure S1A). Wnt signaling emanating from
polarized epithelial-mesenchymal crosstalk in the SC niche is
critical for hair follicle stem cell (HF-SC) activation during tissue
homeostasis (Greco et al., 2009). In addition, localized Wnt
signaling/b-catenin at a wound site initiates the migration of
SCs after injury (Ito et al., 2005, 2007). Based upon these points,
the potential exists for using skin as a model to dissect how
signaling cues to SCsmight regulate the cytoskeleton to orches-
trate cell polarization and directional cell movement. In searching
for potential cytoskeletal regulators in this process, we noticed
that HF-SCs display significantly more actin crosslinkingCell 144, 341–352, February 4, 2011 ª2011 Elsevier Inc. 341
factor-7 (ACF7; also called MACF1, MT and actin crosslinking
factor-1) than other skin epithelial cells (Blanpain et al., 2004;
Morris et al., 2004; Tumbar et al., 2004) (Figure S1B).
Unique to multicellular organisms, spectraplakins such as
ACF7 can bind both MT and actin networks (Jefferson et al.,
2004; Ro¨per et al., 2002). Although broadly expressed, their
essential functions are most clearly revealed in muscle, neurons
and skin epithelial cells, which maintain elaborate yet dynamic
cytoskeletal networks. Mutations in the single Drosophila spec-
traplakin gene (Kakapo/short-stop/shot) cause a wide variety
of cellular and tissue defects that include perturbations in
actin-MT organization, cell-cell adhesion and integrin-mediated
epidermal attachment to muscle. There are two evolutionarily
conserved mammalian counterparts. Mice lacking BPAG1/dys-
tonin display sensory neuron and muscle degeneration and
have gross defects in cytoskeletal organization and function.
By contrast, mice lacking ACF7 exhibit early embryonic lethality
(Chen et al., 2006; Kodama et al., 2003). Recent studies show
that mice conditionally lacking ACF7 display defects in cell
migration. This was true for both K14-Cre cKO animals, impaired
in skin wound healing (Wu et al., 2008) and for Nestin-Cre cKO
mice, defective in brain development (Goryunov et al., 2010).
While the loss of function data underscore the importance of
spectraplakins in coordinating the cytoskeletal dynamics neces-
sary for cells to polarize and move in a directed fashion (Rodri-
guez et al., 2003), the mechanisms underlying the regulation of
spectraplakin-mediated actin-MT connections remain unknown.
Similarly, lacking are the molecular details of the circuitry that
must link upstream signaling pathways to cytoskeletal remodel-
ing in order for SCs to migrate from their niche. In the present
report, we make major inroads into understanding this process.
We identify a link between GSK3b and ACF7 and further reveal
the in vivo relevance of this connection in polarized locomotion
of skin stem cells upon injury.
RESULTS
C-Terminal Tail Interactions Govern Binding between
ACF7 and Microtubules
ACF7’s carboxy-terminal tail (CT) contains a Gas2-related (GAR)
domain and a (GSR-repeat domain (GSR) domain. Previous
studies suggest, and we have confirmed, that both domains are
involved in the interaction with MTs (Sun et al., 2001; Wu et al.,
2008). To obtain structural information on this interaction, we
incubated ACF7(CT) with polymerizedMTs and conducted ultra-
structural analyses. Under saturating conditions [4:1 molar ACF7
(CT):tubulin heterodimer], ACF7(CT) markedly enhanced the
electron density along the MT surface (Figure 1A). When
compared with naked MTs, ACF7(CT)-coated MTs were
10 nm thicker in diameter (projection profile in Figure 1A). Four-
ier transform analyses further indicated that whether decorated
with ACF7(CT) or not, assembled MTs displayed a 40A˚ layer
line corresponding to the packing of tubulin dimers. However,
onlyACF7(CT)-decoratedMTsdisplayeddiscrete 80A˚ layer lines,
suggesting that ACF7 might associate with the MT lattice with
a rather weak distinction between a- and b- tubulins (Figure 1A).
Interaction with the MT lattice usually involves the acidic
C-terminal tails of tubulin subunits that protrude from the MT342 Cell 144, 341–352, February 4, 2011 ª2011 Elsevier Inc.surface. To test this hypothesis, we performed binding assays
between ACF7(CT) and increasing concentrations of taxol-stabi-
lized MTs. Just prior to adding ACF7(CT), we exposed half the
polymerized MTs to subtilisin to shave protruding tubulin tails
(MTDC-tail). Following ultracentrifugation, pellets were then
analyzed by SDS-polyacrylamide gel electrophoresis (PAGE)
and Coomassie Blue (CB) staining. Subtilisin-treated MTs still
pelleted after ultracentrifugation, confirming that MTs remained
assembled after treatment. Only a slight increase was noted in
tubulin’s electrophoretic mobility, consistent with tail removal
(compare asterisked lanes in Figure 1B). However, this modifica-
tionmarkedly diminished ACF7(CT)’s binding toMTs (Figure 1B).
When ACF7(CT)’s concentration was progressively increased,
its association with MTs became saturating, reflected by an
increase in the soluble pool of free ACF7(CT). A Scatchard plot
of the data are shown in Figure 1C. ACF7(CT) binding to
untreated MTs gave a KD of 1.4 3 107 M, which was compa-
rable to published results on GAR and GSR domains of ACF7
(Sun et al., 2001). By contrast, the affinity of ACF7(CT) for subtil-
isin-treated MTs was >103 weaker (KD 1.5 3 106 M).
Phosphorylation of ACF7’s C-Terminal Domain
by GSK3b
Association with tubulin tails usually depends on electrostatic
interactions between acidic tubulin C termini and positively
charged surfaces of MT-binding proteins. Consistent with this
notion, ACF7(CT) contains many lysine (K) and arginine (R) resi-
dues. Particularly, the GSR domain (202 amino acids) harbors
36 strongly basic residues, with a calculated isoelectric point at
11.8. Additionally, 32% of residues in ACF7’s GSR domain are
serine or threonine, suggestive of the potential to regulate
ACF7-MT’s electrostatic interactions through protein phosphor-
ylation. To address this possibility, we transfected primary
keratinocytes with ACF7(CT) and labeled them with [32P]-ortho-
phosphate. Our results showed that ACF7(CT) is efficiently phos-
phorylated in vivo (Figure 1D).
We next analyzed phospho-ACF7(CT) by mass spectrometry.
We circumvented the difficulties posed by ACF7(CT)’s high
percentage of basic residues by choosing protease AspN, which
cleaves peptide bonds N-terminal to aspartate. Liquid chroma-
tography-tandem mass spectrometry (LC-MS/MS) identified
multiple (up to six) phosphorylation sites within a peptide encom-
passing the GSR repeats (Figures 1E and 1F). Interestingly, the
characteristic GSR repeats within this sequence have six serines
that match consensus GSK3b phosphorylation sites [phosphor-
ylation cluster-1 (P1)]. While in silico analysis with different phos-
phorylation prediction algorithms (Obenauer et al., 2003; Schiller,
2007) revealed additional potential GSK3b sites [phosphorylation
cluster 2 (P2), Figure 1F], their incompatible sequence context
precluded efficient peptide retrieval for MS/MS analysis.
To determine whether ACF7 is specifically phosphorylated by
GSK3, we first tested for an endogenous association between
ACF7 and GSK3b proteins in HF-SCs. Immunoblot analyses re-
vealed GSK3b in anti-ACF7 immunoprecipitates of wild-type
(WT) but not ACF7 null cell lysates (Figure 2A). In vitro kinase
(IVK) assays further showed that ACF7 is a substrate for active
GSK3b and that GSK3b phosphorylates ACF7(CT) but not
ACF7-NT (N-terminal domain of ACF7 serving as a control)
Figure 1. Structural Evidence that Electro-
static Interactions and Phosphorylation
May Regulate Associations between ACF7
and MT
(A) Ultrastructural analyses of negatively stained
MTs either decorated with ACF7(CT) or naked.
Data were normalized and are shown super-
imposed in the upper right as 1D projection
profiles along the MT axis. The scale bars repre-
sent 20 nm. A fourier transform of an ACF7-
decorated MT is shown with the 40 A˚ and 80 A˚
layer lines denoted by white arrows.
(B) Cosedimentation assay with ACF7(CT) and
with decreasing amounts (20, 10, 5, and 2.5 mg) of
MTs ± subtilisin. Note small downshift of tubulin
bands (asterisks) and also decreased binding to
ACF7(CT) that occurs following enzymatic treat-
ment of polymerized MTs. MTDC-tail indicates MT
with C-terminal tail removed by subtilisin.
(C) Dissociation constants (Kd) of ACF7’s inter-
actions with MT ± subtilisin. Binding assays were
performed as in (B) but with a range of ACF7(CT)
concentrations. Scatchard plot represents av-
erage of three data sets.
(D) GST-tagged ACF7(CT) was purified from [32P]
orthophosphate-labeled keratinocyte lysates ±
calf intestine alkaline phosphatase (CIP) and sub-
jected to autoradiography and immunoblotting
(IB).
(E) Tandemmass spectrometry peptidemassmap
of AspN-generated peptides from purified ACF7
(CT) protein. Stars (+) denote multiple signals
corresponding to a serine-rich phospho-peptide,
whose deduced sequence is shown.
(F) Diagram of ACF7 with its many domains. The
following abbreviations are used: CH, calponin
homology F-actin binding; EF: EF hand motif
mediating potential Ca2+ binding; GAR-GSR, Gas2-related and GSR repeats for MT binding. GSR repeats contain two potential GSK3b phosphorylation clusters,
shown here, aligned with consensus GSK3b site (phospho-Ser in red, requisite Arg in blue). Figure 1 is associated with Figure S1.(Figure 2B). Moreover, coexpression of GSK3b with ACF7(CT) in
cultured cells resulted in phosphorylation of ACF7 that was
sensitive to treatment of phosphatase (Figure 2C).
To assess whether our identification of GSK3b phosphoryla-
tion sites in ACF7(CT) was correct, we replaced the predicted
GSK3b-targeted serines with alanines and repeated our phos-
phorylation assays in vitro and in vivo. Individually, mutations
in P1 and P2 each reduced overall phosphorylation. Combinato-
rial mutations of both clusters abolished ACF7(CT) GSK3b phos-
phorylation (Figures 2D and 2E).
Phosphorylation of ACF7 by GSK3b Inhibits Microtubule
Binding
Our finding of functional GSK3b phosphorylation sites in ACF7’s
GSR domain hinted a potential role of this signaling event in
tempering ACF7’s MT connection by reducing their electrostatic
affinity. To test this possibility, we had to first overcome the tech-
nical hurdles of ACF7’s enormous size (5380 amino acid resi-
dues) and engineer mammalian expression vectors encoding
human influenza hemagglutinin epitope (HA)-tagged full-length
ACF7 as well as point mutants that converted GSK3b phosphor-
ylation sites at P1 and P2 to either a kinase-refractile versionharboring Ser/Alamutations (S:Amutant) or a phosphomimetic
version, containing Ser/Asp mutations (S:D mutant).
We purified the proteins by affinity chromatography (Wu et al.,
2008) and carried out in vitro cosedimentation assays with poly-
merized MTs (Figure 3A). Both HA-tagged ACF7 and its S:A
mutant counterpart maintained a strong affinity for MT binding
similar to WT ACF7, while ACF7(S:D) exhibited significantly
reduced affinity for MTs. Similar results were obtained when
the binding assays were repeated with freshly prepared lysates
from cells expressing ACF7 or its mutants (Figure 3B). In
contrast to the effects of S:A and S:D mutations on MT-binding
affinity, ACF7’s F-actin-binding affinity and adenosine triphos-
phate (ATP) hydrolysis activity were unaffected (Figures S2A
and S2B).
To directly assess the effects of GSK3b phosphorylation, we
next coexpressed constitutively active GSK3b (caGSK3b, S9A
mutant) with either WT or kinase-refractile ACF7. As predicted,
the MT-binding affinity of WT-ACF7 was reduced when GSK3b
was superactivated (Figure 3C). This effect was specific for
ACF7’s C-terminal GSR domain, since GSK3b did not alter inter-
actions between ACF7(S:A) and MTs (Figure 3C). Consistent
with these results, inhibition of endogenous GSK3b activity byCell 144, 341–352, February 4, 2011 ª2011 Elsevier Inc. 343
Figure 2. GSK3b Associates with and Phosphory-
lates ACF7
(A) Bulge SC lysates were analyzed by SDS-PAGE and IB
before and after immunoprecipitation (IP) with ACF7 and
control IgG Abs. Blots were probed with GSK3b or ACF7
Abs as indicated.
(B) In vitro GSK3b kinase (IVK) assays were performed on
C- or N-terminal ACF7. Phosphorylation was analyzed by
SDS-PAGE and autoradiography.
(C) Lysates are from cultured cells expressing HA-tagged
ACF7(CT) ± constitutively active (ca) GFP-tagged GSK3b
(or Ctrl vector) ± CIP phosphatase. Lysates were
analyzed ± anti-HA IP by SDS-PAGE and anti-phospho-
serine/threonine (Pi-Ser/Thr) immunoblotting.
(D) Cells were transfected with plasmids encoding WT or
GSK3-site mutants (see Figure 1F) of HA-tagged ACF7
(CT) (or HA-tagged GST control) and caGSK3b or control
vector. After labeling with [32P]-orthophosphate, proteins
were subjected to anti-HA IP, SDS-PAGE, staining, and
autoradiography. HC is an abbreviation for IgG heavy
chain.
(E) Recombinant kinase was used to test GSK3b phos-
phorylation of ACF7(CT) and its different mutants in vitro.
Phosphorylation of ACF7(CT) was detected by IB with Pi-
Ser/Thr Ab.exposing HF-SCs to different GSK3-specific inhibitors signifi-
cantly increased the MT-binding affinity of endogenous ACF7
(Figure 3D). Together, these findings provided compelling
support for GSK3b as an important regulator of ACF7’s associa-
tion with MTs and showed that GSK3b-mediated regulation was
exerted exclusively at P1 and P2 of the ACF7’s GSR domain.
TheWound-Healing Delay in ACF7-Deficient Skin Arises
From Defective HF-SC Migration
Previously, we showed thatmice targeted for loss of ACF7 in skin
are defective in wound repair (Wu et al., 2008), a process known
to involve HF-SCs (Ito et al., 2005; Tumbar et al., 2004). When
coupled with the appearance of ACF7 on the list of genes upre-
gulated in HF-SCs (Figure S1B) and an emerging role for Wnt
signaling in wound repair (Fathke et al., 2006; Ito et al., 2007; Sto-
ick-Cooper et al., 2007), our finding of GSK3b as a potential
regulator of ACF7 took on newfound importance and merited
further investigation.
To begin to evaluate how ACF7 functions in this pathway, we
first purified HF-SCs (CD34hia6-integrinhi) by fluorescence acti-
vated cell sorting (FACS) versus other basal cells (CD34nega6-in-
tegrinhi) (Blanpain et al., 2004). RT-PCR and immunoblot on
these purified cell populations verified ACF7’s enrichment in
HF-SCs at bothmRNA and protein levels (Figure 4A). Immunoflu-
orescence further documented elevated ACF7 in this niche
throughout the hair cycle (Figure 4B).
Loss of ACF7 in HF-SCs did not alter bulge architecture (data
not shown) nor did it affect expression of key bulge markers
(Blanpain and Fuchs, 2009) (Figure 4C). In addition, no significant
changes were found in proliferation or apoptosis of homeostatic
HF-SCs (more details below) or in hair growth or cycling (Wu344 Cell 144, 341–352, February 4, 2011 ª2011 Elsevier Inc.et al., 2008). We therefore focused on the hypothesis that the
associated defects in wound repair originate from perturbations
in HF-SC migration. To test this, we bred our ACF7fl/fl animals
with mice expressing a progesterone-regulatable recombinase
(K15-Cre-PGR) specifically in bulge SCs (Ito et al., 2005). To
monitor HF-SC progeny in a wound response, we further bred
these mice to Rosa26-lox-Stop-lox-LacZ reporter animals.
As expected, treatment of adult mice with RU486 (a proges-
terone antagonist) activated Cre and selectively marked
HF-SCs. When challenged to a wound, activated LacZ+ bulge
cells exited the niche and migrated upward to re-epithelialize
wounded epidermis (Figure 4D). This was readily observed by
whole-mount staining, which displayed trails of HF-SC-derived
blue (LacZ+) cells emanating from perilesional follicles of
wounded tissue (dashed arrows). By contrast, ACF7 cKO bulge
cells were delayed in this process by 40% compared with WT
controls over 4–6 days after injury (Figures 4D and 4E). Impor-
tantly, since targeting was specific to bulge cells, the delay
was directly attributable to an SC defect. Moreover, ACF7-defi-
ciency did not affect proliferation or apoptosis of bulge SCs, indi-
cating that the defect was rooted in cell migration (Figures S3A
and S3B).
To examine the contribution of GSK3b in this process, we took
a pharmacological approach to manipulate GSK3b activity
in vivo. Wounds onWT skin were treated with either lithium chlo-
ride (LiCl), which directly inhibits GSK3b, or wortmannin, which
activates GSK3b by inhibiting an upstream regulator, phosphoi-
nositol-3 kinase (PI3K). Interestingly, both treatments impaired
wound-induced cell migration out of the adult HF-SC niche (Fig-
ure 4F), suggesting that spatiotemporal regulation of GSK3b’s
activity is required to achieve efficient bulge SCmigration in vivo.
Figure 3. GSK3b Phosphorylation of ACF7’s GSR
Domain Inhibits Microtubule Binding
(A) In vitro binding assays on purified ACF7 proteins. After
incubating with 0–20 mg taxol-stabilized MTs, purified WT,
or mutant versions of full-length, HA-tagged ACF7 were
cosedimented and subjected to IB analyses. Note that
phosphomimetic S:D but not phosphorylation-refractile
S:A ACF7 shows significantly reduced binding affinity.
(B) In vivo MT-binding assays. Lysates were prepared
from cells expressing HA-tagged ACF7 or ACF7 mutants,
and cosedimentation assays were performed as in (A).
(C) Lysates were prepared from cells coexpressing
caGSK3 with HA-tagged ACF7 or ACF7(S:A). Cosedi-
mentation assays and IBs were as in (A).
(D) Lysates were prepared from untreated cells or cells
treated with GSK3b inhibitors (1: LiCl, 2: AR-A01448).
Cosedimentation assays and IBs were as in (A). Figure 3 is
associated with Figure S2.The Polarization of MTs along Actin-Focal Adhesion
Networks is Abrogated When ACF7 Is Phosphorylated
by GSK3b
Previously, we showed that when ACF7 is ablated, cultured
epidermal keratinocytes cannot coordinate microtubule growth
along F-actin filaments, a feature that in turn leads to overstabili-
zation of focal adhesions (FAs) and defective cell movement (Wu
et al., 2008). Based on our results thus far, we posited that in vivo,
HF-SCs might respond to migratory stimulations such as Wnt
signaling by spatiotemporally regulating ACF7-MT connections
and promoting the cytoskeletal remodeling needed for polarized
migration. To test this hypothesis, we first generated phospho-
specific ACF7 Abs against two synthetic phospho-peptides cor-
responding to the ACF7 GSR sequences encompassing P1 and
P2, respectively. Each Ab was specific for the phosphorylated
state of its GSK3b target sequence: when ACF7 was not phos-
phorylated or when the sites were selectively mutated, the Abs
failed to recognize the ACF7 protein (Figures S4A and S4B).
Isolated HF-SCs can sustain long-term culture without losing
stemness (Blanpain et al., 2004), allowing us to investigate the
role of ACF7 phosphorylation in vitro. Both ACF7 Abs detected
the expected sized band in immunoblots of cultured bulge SC
but not ACF7 cKO lysates (Figure 5A). Importantly, these signals
were sensitive not only to chemical inhibitors of GSK3b but also
to recombinant Wnt3a. These data confirmed the specificity of
our phospho-specific Abs and further demonstrated the ability
of Wnt signaling to repress ACF7 phosphorylation in its
C-terminal tail.
We next examined the GSK3b phosphorylation status of
endogenous ACF7. In vitro, ACF7 decorated the ends of MTs
that are coaligned with underlying F-actin cables (Figure 5B).Cell 144, 34By contrast, phospho-ACF7 was diffuse and/
or punctate throughout the cytoplasm and
showed no association with these MT cables
(Figure 5C). Nevertheless this cytoplasmic
staining was specific for ACF7, as it was abol-
ished in ACF7 KO bulge cells (Figure 5C). These
findings were consistent with the phospho-
dependent decreased affinity of ACF7 for MTsthat we observed in vitro and revealed a marked correlation
between GSK3b phosphorylation of ACF7 and a severing of
the ACF7-MT connection.
To directly evaluate the effect of GSKb phosphorylation on this
process, we overexpressed caGSK3b in WT cultured bulge SCs.
In contrast to empty vector alone (Figure 5D, left), caGSK3b
dramatically reduced ACF7 localization along MTs (Figure 5D,
center). Moreover, and quite remarkably, expression of constitu-
tively active GSK3b transformed the straight and radial MTs of
WT cells into a network of bent and curly MTs, reminiscent of
the aberrant MT network typifying ACF7 KO cells (Figure 5D,
compare with data in Figure 5C).
If GSK3 activation and phosphorylation of ACF7 is responsible
for severing the polarization of MTs at the migrating front, then
inhibiting endogenous GSK3b activity might be expected to
stabilize these connections. Indeed, when we treated HF-SCs
with LiCl, under conditions that potently inhibited GSK3b activity
and ACF7 phosphorylation, ACF7 clustered at the ends of MTs
(Figures 5A and 5E). Additionally, polarized sites of converging
ACF7, MT, and F-actin usually colabeled with Abs against FA
proteins (Figure S4C).
ACF7-deficiency stabilizes FA through inhibiting MT targeting
to FA (Wu et al., 2008). However, when DsRed-Zyxin-expressing
HF-SCs were subjected to videomicroscopy and quantified, the
effects of LiCl on FA turnover were modest (Figure S4D, Movie
S1). This was also the case for the average size of FAs and the
level of focal adhesion kinase (FAK) activity, which influence FA
dynamics as well (Figures S4E and S4F). Overall, these results
suggest that constitutive association between ACF7 and MTs
may not elicit the alterations in FA stability that are seen when
ACF7 is missing altogether.1–352, February 4, 2011 ª2011 Elsevier Inc. 345
Figure 4. Loss of ACF7 Impairs Migration of
Bulge Stem Cells In Vivo and In Vitro
(A) RT-PCR (upper left), IB (upper right) and
quantifications (lower) of ACF7 mRNA (real-time
RT-PCR) and protein from isolated bulge HF-SCs
and non-SC extracts. Error bars denote standard
deviation (SD).
(B) Immunofluorescence of skin sections at
different hair cycle stages. ACF7 is enriched in
bulge (arrows), and although CD34 is present in
dermis, its epithelial expression is specific to
bulge. Color coding is according to secondary
Abs used in detection. Nuclei were counter-
stained with DAPI (blue). Dashed lines denote
basement membrane. The following abbrevia-
tions are used: HF, hair follicle; der, dermis; epi,
epidermis; DP, dermal papilla. The scale bars
indicate 50 mm.
(C) Immunofluorescence of sections of HF bulges
(arrows) for SC markers indicated.
(D and E) Whole-mount LacZ imaging and quan-
tifications of bulge SCs and their progeny from
perilesional follicles of WT and ACF7 cKO mice.
Dashed lines denote wound boundary; dashed
arrows denote trails of bulge SCs and progeny
that migrated into wound. The inset is of
unwounded K15-Cre-activated skin where LacZ
expression is confined to the bulge, not visible on
the body surface. Blue cells migrated upward
only after wounding. The length of the blue cell
trails 4 or 6 days after wounding (P4 and P6) was
quantified in (E) by box-whisker plots.
(F) Wounded animals were topically treated with
LiCl or wortmannin (Wort). Bulge SC migration
was quantified as in (E). Figure 4 is associated
with Figures S1 and S3.GSK3b has many targets, which complicates the interpreta-
tion of LiCl experiments (Sun et al., 2009). To distinguish the
specific effects of GSK3b on ACF7-mediated cytoskeletal
dynamics, we performed rescue experiments with our ACF7
phosphorylation mutants. To more precisely control concentra-
tion and ensure comparable expression of encoded proteins,
we microinjected our expression constructs into primary
cultured HF-SCs null for ACF7.
Introducing GFP-tagged versions of either full-length or S:A
mutant ACF7 restored ACF7’s localization to the MT ends
residing near or at the cortex (Figure 5F). Consistent with their
MT-binding capability, kinase-refractile ACF7(S:A) and full-
length ACF7 also generated arrays of radial MT trajectories in
individual ACF7 null cells (Figure 5F). By contrast, the phospho-
mimetic ACF7(S:D) was diffusely localized, and its MT organiza-
tion appeared no different than in uninjected or GFP-injected
ACF7 null cells (Figure 5F). Taken together, these experiments
provide compelling evidence that GSK3b plays a critical role in
regulating ACF7’s dissociation from MTs and that phosphoryla-
tion is sufficient to dramatically alter polarized organization of
MTs along actin stress fibers converging at FAs.346 Cell 144, 341–352, February 4, 2011 ª2011 Elsevier Inc.GSK3b Phosphorylation of ACF7 Must Be Dynamic
to Govern Polarization and Directed Movement
in Cultured HF-SCs
Cultured HF-SCs further allowed us to examine their directional
movement in vitro. When subjected to a modified Boyden
chamber assay with conditioned feeder fibroblast medium as
a chemo-attractant, WT HF-SCs showed a marked, dose-
dependent migratory response, which was greatly diminished
in HF-SCs lacking ACF7 (Figure 6A). Moreover, stimulation of
WT HF-SCs’ migration was achieved only when conditioned
medium was administered in a positive concentration gradient.
These data further documented the chemotactic nature of the
response, and confirmed ACF7’s role in sustaining directional
cell movement. Consistent with our in vivo observations, treat-
ment of HF-SCs with GSK3b inhibitors or ectopic expression
of caGSK3b inhibited the response (Figure 6B).
Directionality of movement relies heavily on cell polarity, and
prior studies indicated that embryonic endodermal cells lacking
ACF7 cannot sustain cell polarity after scratch-wounding in vitro
(Kodama et al., 2003). To evaluate how regulated ACF7-MT
connections might contribute to cell polarity, we devised
Figure 5. ACF7 Is Required to Polarize MTs along
F-Actin-Focal Adhesion Networks, which in Turn
Are Inhibited by GSK3b Activity
(A) ACF7 protein and its phosphorylation status were
evaluated by immunoblot of lysates from KO or WT bulge
SCs treated with GSK3b inhibitors or Wnt3a, as indicated.
(B and C) Cultured bulge SCs immunolocalized for
a-tubulin (MT), ACF7, ACF7 phosphorylation (ACF7-Pi,
with P2-specific Abs), or F-actin (phalloidin). Notes: (1)
ACF7 but not phospho-ACF7 is enriched at polarized MT
tips and (2) the diffuse cytoplasmic ACF7-Pi pattern of WT
is absent in KO cells.
(D) Immunofluorescence of WT bulge SCs expressing
caGSK3b or vector control. Transfected cells are marked
with arrows. Note: caGSK3b inhibits ACF7 localization at
MT tips and leads to disorganized MT networks.
(E) WT bulge cells were treated with LiCl to impair GSK3b
activity and subjected to immunofluorescence as indi-
cated. Note clusters of ACF7 at cell periphery.
(F) Cultured ACF7 KO bulge SCs were microinjected with
expression vectors encoding GFP alone, GFP-ACF7
(rescue), GFP-ACF7(S:A) (GSK3-refractile), or GFP-ACF7
(S:D) (phosphomimetic). Cells were immunolabeled for
MTs. Note that only WT and S:A mutant, and not GFP or
S:D mutant, localized and rescued MT organization
defects that occur in KO bulge SCs in low-Ca2+ medium.
Wherever the field includes uninjected cells, injected ones
are denoted by an asterisk.
For (B–F), boxed areas are magnified in insets. The scale
bars represent 20 mm. Figure 5 is associated with Fig-
ure S4.a method to polarize cultured bulge SCs by seeding them at low
density on fibronectin-coated dishes and then elevating Ca2+
levels to induce cell-cell adhesion. Under these conditions, the
perimeter of isolated WT colonies exhibited significant polarity
as determined by immunolocalization of phosphorylated (inac-
tive)GSK3b, Par proteins, and aPKC (Figure 6C, andFigure S4G).
Polarization of perinuclear Golgi was particularly prominent,
enabling quantification by measuring its preferential localization
around the axis bisecting nucleus and colony edge. Interestingly,
ACF7-deficient bulge SCs displayed polarized GSK3b phos-
phorylation but not Golgi (Figure 6C). Moreover, manipulating
GSK3b activity in WT HF-SCs disrupted Golgi polarization (Fig-
ure 6D). These data placed ACF7 midstream in the pathwayCell 144, 34that links polarized GSK3b inhibition at the HF-
SC front and Golgi polarization in the perinu-
clear region.
Our findings were intriguing in light of prior
data showing that MTs are essential for polar-
izing Golgi assembly (Miller et al., 2009; Siegrist
and Doe, 2007). We therefore wondered
whether rescuing the ability of MTs to polarize
along actin cables might also rescue defective
Golgi polarization. To test this possibility, we
repeated the polarization assays, this time with
bulge SCs microinjected with our GFP-tagged
versions of WT and phosphorylation-altered
ACF7. WT-ACF7 rescued polarization of HF-
SCs (Figure 6D). As expected from its failure tobindMTs (Figure 5F), ACF7(S:D) also failed to effectively polarize
Golgi (Figure 6D). Interestingly, however, even though ACF7(S:A)
efficiently rescued MT organization (Figure 5F), it failed to rescue
Golgi orientation (Figure 6D).
Finally, we tested the ability of our mutants to rescue the
chemotactic migration defects seen in ACF7 null cells. As shown
in Figure 6E, only WT-ACF7 rescued the ability of bulge SCs to
migrate efficiently. Together, these data showed that the ability
of MTs to track along actin cables is not sufficient to achieve
either polarization or effective migration of bulge SCs. Moreover,
both of these processes require in addition the dynamic regula-
tion of ACF7 phosphorylation since neither the phosphomimetic
mutant, the phosphorylation refractile mutant, nor the two1–352, February 4, 2011 ª2011 Elsevier Inc. 347
Figure 6. GSK3b Phosphorylation Governs
ACF7 Functionality in Cell Polarity and
Directional Cell Movement in Vitro
(A) Isolated HF-SCs were subjected to modified
Boyden chamber assays, and a checkerboard
analysis was performed to distinguish chemo-
kinesis versus chemotaxis effects. Feeder-condi-
tioned medium was used as chemoattractant and
was mixed with serum-free medium to load into
upper and lower chambers. Migration was quan-
tified as in Experimental Procedures, and pre-
sented as bar graphs. Color coding corresponds
to the concentration of chemoattractants in the
lower chamber. Concentrations of chemo-
attractants in upper chamber are indicated in bar
graph legends. Note that only WT cells showed
significant chemotactic behavior when exposed to
a positive chemoattractant gradient.
(B) Migration of treated or transfected WT HF-SCs
was examined as in (A), with only 0 or 100% of
chemoattractants used in lower chamber and no
chemoattractants in upper chamber. Note that
both global inhibition and artificial activation of
GSK3b activity inhibit migration of HF-SCs.
(C) Immunofluorescence detects Ser-9 GSK3b
phosphorylation (inactivation), GM-130 (Golgi),
E-cadherin (E-Cad), and chromatin (DAPI). Arrows
denote enriched phospho-GSK3b at the leading
edge. Dashed lines denote colony perimeters.
q represents angle between solid arrow, denoting
outward direction of HF-SC colony and dashed
arrow, denoting Golgi orientation. Note polariza-
tion of inactivated GSK3b at migrating edge of
both WT and ACF7 null HF-SCs, and loss of Golgi
polarization in ACF7 null HF-SCs. The scale bar
represents 20 mm.
(D) Windrose plots of Golgi orientation (quantifi-
cation of angle q) in treated or untreated WT and
microinjected or uninjected ACF7-deficient cells.
Note random distribution of q in KO cells; only WT
ACF7 restores proper cell polarity.
(E) Quantifications of chemotactic behaviors show
that only WT ACF7 rescues migration defects in
ACF7 null bulge SCs. Error bars represent SD.mutants combined (Figure 6E) were able to rescue these defects
in KO cells.
GSK3b Phosphorylation of ACF7 Regulates Bulge SC
Migration and Skin Wound Repair In Vivo
We next focused on whether dynamic regulation of ACF7 phos-
phorylation coordinates polarized bulge SC migration during
wound repair in vivo. We began by engineering transgenic
mice expressing N-terminally GFP-tagged, full-length versions
of ACF7 and ACF7 S:A under the control of K14 promoter and
enhancer. Mice genotypic for K14-ACF7 or K14-ACF7(S:A)
alleles were born in the expected Mendelian numbers and
grew normally (Figure S5A). Transgenic ACF7 and ACF7(S:A)
GFP-tagged proteins of the correct size were expressed compa-
rably and exhibited the expected differential GSK3b phosphory-
lation states in vivo (Figure S5A). Immunofluorescence
confirmed skin-specific transgene expression (Figure S5B).
To determine the ability of these transgenic proteins to
compensate for loss of ACF7 in HF-SCs in vivo, we bred our348 Cell 144, 341–352, February 4, 2011 ª2011 Elsevier Inc.transgenics to ACF7fl/fl:K15-Cre-PGR:Rosa26-LacZ mice and
then induced ablation of endogenous ACF7. Mice expressing
these transgenes and not ACF7 in their HF-SCs were visibly
normal, and no gross differences were noted in hair cycles (Fig-
ure S5C; data not shown). Immunofluorescence for a variety of
differentiationmarkers showed normal morphology and localiza-
tion patterns (Figures S5D and S5E).
Given the normal tissue architecture and homeostasis, we next
turned to investigating how ACF7’s GSK3b-phophorylation
status affects the ability of HF-SCs to respond and migrate
outward to repair epidermis upon skin wounding. In response
to punch wounds, only ACF7 cKO mice expressing GFP-ACF7,
and not GFP-ACF7(S:A), showed significant rescue of bulge SC
migration defects, as measured by LacZ whole-mount staining
(Figure 7A, left). This difference appeared to reflect a differential
ability to restore directional cell movement, since bulge SCprolif-
eration and apoptosis assays showed no change (Figures S3A
and S3B). Although most data shown are for K15-Cre-PGR,
similar results were obtained when the wounding challenge was
Figure 7. GSK3b Phosphorylation of ACF7
Plays a Critical Role in Bulge Stem Cell
Migration and Skin Wound Repair In Vivo
(A) Box and whisker plots (left) and bar graphs
(right) show that in vivo migration of HF-SCs and
overall skin healing (length of hyperproliferative
epithelium in wound) were restored by WT-ACF7
transgene but not ACF7(S:A). Stars (+) represent p
value less than 0.05, and error bars represent SE.
(B) Outline of methodology used to activate and
induce migration of quiescent HF-SCs in skin
biopsy (1) by ex vivo wounding. A typical telogen
HF is shown in (2) with arrows marking potential
direction of HF-SC migration upon wounding. HF-
SCs are identified by C12-FDG (a fluorogenic
substrate of LacZ), and outward migration is
visualized by phase contrast (PhC) or fluorescence
microscopy. Dashed lines denote basement
membrane in (2), or migrating front in (3–4). Stars
denote C12FDG(+) cell in (4).
(C) Representative examples of SC progeny after
exiting and migrating out of the HF bulge. Immu-
nofluorescence was used to visualize ACF7, MT,
and F-actin. Boxed areas are magnified as insets.
(D–E) Cells migrating out of the bulge SC niche
were immunostained for phospho-GSK3b and
phospho-ACF7. Note enrichment of inactive
(phosphor) GSK3b at migrating front and corre-
sponding lack of GSK3b-phosphorylation of ACF7
at plus ends of MTs localized there.
(F) Live imaging of progeny that migrated out of the
bulge SC niche during wound response. Cells
were microinjected to express GFP-EB1, and
MT +tip movements were then monitored by
videomicroscopy and tracked automatically
(upper). Corresponding MT behavior is color-
coded and described in text and Experimental
Procedures. Data for directionalities of MT growth
were collected from movies and then quantified
and presented as Windrose plots (lower). Arrow
denotes direction toward wound front. Dotted
lines denotemigrating front of cells streaming from
the wound-induced skin explant. The scale bar
represents 20 mm. Figure 7 is associated with
Figures S5 and S6.broadened by using transgenic mice mated to ACF7fl/fl: K14-Cre
mice. Once again, the area of hyperproliferative epithelium that
typically migrates into the wound site was only significantly
rescued byGFP-ACF7 and not GFP-ACF7(S:A) (Figure 7A, right).
Finally we addressed whether changes in GSK3b activity alter
ACF7’s ability to coordinate actin- MT dynamics during wound-
induced directed migration of bulge SCs out of HFs. For this
purpose, we induced a rapid wound response in HFs by cutting
the skin at the resting (telogen) phase and placing it into rich
medium. In a process analogous to wound healing, the outward
migration of activated HF-SC progeny could then be imaged by
videomicroscopy and immunofluorescence (Figures 7B–7F and
Figure S6).
Targeted bulge cell progeny were identified by their ability to
cleave a fluorogenic substrate for LacZ (Figure 7B). Consistent
with our in vitro results, Golgi complex as well as Par6 and
aPKC localized in a polarized fashion in WT bulge SCs at theleading front (Figure S6A). These cells also contained FAs (Fig-
ure S6A) and well-polarized MT bundles that coaligned with
F-actin, and ACF7 localized at the interface between these
MT +tips and F-actin bundles (Figure 7C). Loss of ACF7 resulted
in disorganized MT architecture (Figure 7C). Additionally, ACF7
deficiency or change in GSK3b activity led to perturbations in
cell polarity and migration of the marked bulge SCs/progeny
that were streaming from the HFs. Interestingly, while both WT
and S:A mutant ACF7 rescued the disorganized MT network,
only WT ACF7 rescued alterations in cell polarity and migration
(Figure 7C and Figures S6B and S6C).
Similar to our in vitro results (see Figure 6C) and those obtained
from other model systems (Sun et al., 2009), Ser9-phosphory-
lated (inactive) GSK3b was enriched at the leading edge of
migrating HF-SCs (Figure 7D). Consistent with these data, the
majority of ACF7 phosphorylated by GSK3b was localized in
the cell body and not at the leading edge of HF-SCs (Figure 7E).Cell 144, 341–352, February 4, 2011 ª2011 Elsevier Inc. 349
As a +tip protein, ACF7 can guide movement of MT plus ends.
To monitor potential polarity of MT dynamics during wound-
induced migration, we microinjected migrating bulge SCs/
progeny with a GFP-tagged EB1 expression vector. Videomicro-
scopy combined with automated tracking of this plus end (+tip)
MT-binding protein revealed polarized MT growth toward the
migrating front of WT HF-SCs (Movies 2 and Figure 7F). Direc-
tionality of MT growth was largely randomized in KO cells, and
only WT-ACF7, and not ACF7(S:A), rescued it (Figure 7F). Taken
together, these findings underscore an essential physiological
role for GSK3b-mediated phosphorylation of ACF7 in sustaining
polarized MT growth and directed HF-SC migration during
wound healing.
DISCUSSION
Aberrant mobilization of SCs in response to injury can delay
wound repair and have dire consequences to animal survival
(Fuchs, 2009). Exposed to frequent mechanical stresses, skin
SCs have developed a unique and elaborate cytoskeletal
system. However little is known about how cytoskeletal
dynamics are coordinated in these or other SCs. In this report,
we’ve demonstrated the role of ACF7 and ACF7-mediated cyto-
skeletal dynamics in SCs in vivo. Our studies show that ACF7 is
required for efficient upward migration of bulge cells in response
to wounding and that this function is primarily rooted in ACF7’s
ability to coordinateMT dynamics and polarize HF-SCs. Through
a comprehensive approach encompassing biochemistry and
molecular and cell biology, we further unveiled a hitherto unrec-
ognized regulatory role for GSK3b-mediated phosphorylation of
ACF7’s major MT-binding domain. We show that the conse-
quence of this phosphorylation is the attenuation of interactions
between ACF7’s basic GSR domain and the acidic C-terminal
tubulin tails.
Polarized cell movement is an essential component of diverse
biological processes such as cancer metastasis, tissue develop-
ment, and wound healing (Lauffenburger and Horwitz, 1996). All
these processes share significant similarities regarding their
mechanisms for sensing directional cues and translating them
into directional locomotion. Cells under the influence of various
chemotactic molecules exhibit polarized activation of signaling
proteins, such as the CDC42 Rho GTPase and PI3K, that guide
differential remodeling of cytoskeletons at the leading edge
versus the back of cells (Etienne-Manneville, 2004; Siegrist and
Doe, 2007).
MTs play a particularly important role in this process, deliv-
ering positional information to establish the proper site of cortical
polarity (Siegrist and Doe, 2007). Once MTs and their associated
proteins determine the polarity site, a positive feedback loop
initiates interactions between the actin-rich cortex and growing
(plus) ends of MTs, resulting in reinforcement and maintenance
of polarity. Such a mechanism not only provides cells with the
ability to sense and amplify small asymmetries in their field but
also buffers and maintains the polarity axis after it is established.
Common components of MT-based polarity pathways are plus-
end-directed kinesin motors and MT plus-end-stabilizing
proteins, including CLIP-170, EB1, Clasps, and adenomatous
polyposis coli (APC) (Akhmanova and Steinmetz, 2008). Our prior350 Cell 144, 341–352, February 4, 2011 ª2011 Elsevier Inc.studies added ACF7 to this list (Karakesisoglou et al., 2000; Ko-
dama et al., 2003; Wu et al., 2008). Our current study lends phys-
iological relevance for ACF7’s ability to polarize MTs and iden-
tifies a specific role for this connection in enabling HF-SCs to
polarize and migrate into a wound site. In addition, our results
elucidate a hitherto unappreciated signaling pathway whereby
ACF7’s function is regulated dynamically in HF-SCs by GSK3b
in order to control the directionality of MT growth, cell polarity,
and migration.
GSK3b modifies various regulatory components of MT cyto-
skeletons, including APC and some neuronal MT-associated
proteins (Sun et al., 2009). Intriguingly, a recent study showed
that ErbB2-induced repression of GSK3 is required for MT
capture and targeting of ACF7 to plasma membrane in breast
carcinoma cells (Zaoui et al., 2010). Our results identify ACF7
as a GSK3b substrate in skin somatic SCs and raise the possi-
bility that GSK3b may function as a master regulator of MT
polarity. Importantly, however, our findings reveal that although
only phosphomimetic ACF7 mutants disrupt MT organization,
nonphosphorylatable ACF7 mutants nonetheless impair global
cell polarization and SC migration. These findings underscore
the importance of regulating ACF7’s phosphorylation status in
a spatially and temporally defined manner in order to establish
proper directionality in cells.
Consistent with this notion, GSK3b activity is specifically in-
hibited by CDC42 signaling at the leading edge of migrating
cells (Etienne-Manneville and Hall, 2003; Sun et al., 2009)
and also by Wnt signaling, which is often polarized in tissues
(Nusse, 2008). Notably, Wnts have been broadly implicated in
wound repair and are required for HF-SC activation at the start
of the hair cycle (Blanpain and Fuchs, 2009). Although ACF7
has been implicated in recruiting the Axin-APC-GSK3b
complex to the site of active Wnt signaling in the gastrulating
embryo (Chen et al., 2006), an essential role in Wnt signaling
would not explain why SC activation and hair cycling still occur
in ACF7 cKO skin. Our findings now provide an alternative role
for ACF7 in Wnt signaling, namely as a downstream sensor of
GSK3b inhibition and a mobilizer of the polarized response
necessary for SC migration. Collectively, our findings support
a model in which upstream chemotactic cues, e.g., Wnt
signaling, trigger cellular polarization, and directional move-
ment through spatiotemporal regulation of ACF7 phosphoryla-
tion by GSK3b (Figure S7). In this model, some outcomes of
Wnt signaling and GSK3b inhibition, e.g., SC activation, prolif-
eration, and fate commitment in normal homeostasis, might
still be maintained while others, e.g., SC migration during
wound repair, would rely upon the ability to polarize directed
migration. Future studies will determine the extent to which
this pathway can explain ACF7’s broad and essential presence
in tissues.
In closing, our findings provide insights into the complex but
important molecular machinery underlying the polarized SC
migration that integrates injury-induced migratory signals,
cytoskeletal remodeling, and polarized cell movements in HF-
SCs. Our studies also add to the repertoire of spectraplakin’s
many diverse and critical functions and now pave the way for
probing more deeply into the role of spectraplakins in mam-
malian SCs.
EXPERIMENTAL PROCEDURES
Generation of Transgenic Mice and Skin Wound Healing
The transgenic expression cassette was constructed so that GFP-ACF7 or
GFP-ACF7(S:A) cDNA sequence was inserted 30 to the human K14 promoter
and enhancer and b-globin 50UTR, and 50 to the K14 30UTR. Mice harboring
these transgenes were engineered in Fvb/n albino mice and selected for their
comparable expression relative to endogenous ACF7.
Skin-wound-healing assays were performed as described (Wu et al., 2008).
To monitor the migration of SCs and their progeny after wounding, we treated
K15-Cre-PGR:R26-LacZ:ACF7fl/fl mice ± transgene with RU486 for 5 days
starting at their first telogen (P21). At 8 weeks, mice were anesthetized and
full-thickness punch wounds (6 mm) were introduced on their backs. Skin
samples were then collected at 4 or 6 days after wounding and b-galactosi-
dase activity was detected in whole-mount tissues by X-gal staining (Ito
et al., 2005). For each genotype, at least ten mice were analyzed for the wound
response.
Tomonitor the activation andmigration of SCs from resting HFs subjected to
wound response, we took 3 mm biopsies from back skin of 2-month-old K15-
Cre-PGR:R26-LacZmice that were treated with RU486. Biopsies were coated
with a thin layer of matrigel for adhesion and immediately transferred to
a coverslip coated with 10 mg/ml fibronectin. Skins were then incubated at
room temperature for 10 min to solidify the matrigel and then exposed to
rich E-media containing 15% serum and 0.3 mM calcium (Blanpain et al.,
2004), which promoted HF-SC outgrowth within 2–3 days, analogous to
a wound response. Live HF-SCs and progeny were identified with fluorogenic
b-galactosidase substrates C12FDG or C12RG (Invitrogen, yield green or red
fluorescence respectively) according to the manufacturer’s instruction.
Cell Migration Assays and Time-Lapse Videomicroscopy
Migration assays in 96-well chemotaxis chambers (Millipore, Billerica, MA)
were carried out according to manufacturer’s instructions. Briefly, 3T3 fibro-
blast-conditioned medium or serum-free medium (control) was added to the
lower chamber. Bulge SCs were added to the upper chamber, and, after
10 hr at 37C, cells that migrated through the filter into the bottom chamber
were collected, lysed, and stained with CyQuant GR dye (labels DNA). A fluo-
rescence plate reader was used to quantify fluorescence intensities.
To track individual HF-SC movement, skin biopsies were imaged with an
Olympus phase contrast microscope for 1 day and manually tracked with
National Institutes of Health’s ImageJ. Displacements along the direction
facing the leading edge of the migrating front were recorded and quantified
(Wu et al., 2008). To monitor MT plus end movement in live cells, we microin-
jected HF-SCs with plasmid encoding GFP-EB1. Six hours after injection, cells
were imaged with a confocal spinning-disk microscope (Wu et al., 2008) for
5 min at 2 s/frame. Plus Tip Tracker software package (Matov et al., 2010)
was used to process and track EB1 movements at the leading front. Because
of MT dynamic instability, some gaps appeared between MT growth (red solid
tracks in the output image of Figure 7F). Gaps could occur in either the forward
or backward direction depending on underlying MT dynamics and detection
performance. Forward gaps could be a MT pause (cyan dotted) or reclassified
as growth (green solid). Backward gaps could be MT shrinkage/catastrophe
(yellow dotted) or reclassified as pause events (blue dotted). The same color
codes were used in the output movie (Movie S2), and initiation of a new growth
track or gap wasmarked by a circle with corresponding color. Angles between
MT growth track and outward direction of explants were calculated with
a linear fit function of Matlab and plotted as Windrose plots.
Microtubule Cosedimentation Assay, Subtilisin Treatment,
and Immunoblotting
MT-binding assays were performed as described (Wu et al., 2008). Equivalent
amounts of pellet were analyzed by CB staining or immunoblotting. Cleavage
of the unstructured tubulin C terminus was carried out by limited proteolysis of
taxol-stabilized MTs with subtilisin (Knipling et al., 1999). The proteolysis
reaction was stopped by adding freshly prepared 20 mM PMSF in DMSO.
Subtilisin-treated MTs were pelleted by ultracentrifugation at 60,000 3 g and
resuspended in MT-stabilizing buffer containing 20 mM PMSF and taxol to
ensure complete removal of active protease and cleaved C-terminal tubulinfragments. Immunoprecipitations and immunoblotting were performed as
described (Wu et al., 2004).SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two movies and can be found with this article online at
doi:10.1016/j.cell.2010.12.033.
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